171 related articles for article (PubMed ID: 19433600)
1. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype.
Bevins CL; Stange EF; Wehkamp J
Gut; 2009 Jun; 58(6):882-3; discussion 883-4. PubMed ID: 19433600
[No Abstract] [Full Text] [Related]
2. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
3. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
Wehkamp J; Wang G; Kübler I; Nuding S; Gregorieff A; Schnabel A; Kays RJ; Fellermann K; Burk O; Schwab M; Clevers H; Bevins CL; Stange EF
J Immunol; 2007 Sep; 179(5):3109-18. PubMed ID: 17709525
[TBL] [Abstract][Full Text] [Related]
4. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
Tan G; Zeng B; Zhi FC
Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
[TBL] [Abstract][Full Text] [Related]
6. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
8. Mouse Paneth cell antimicrobial function is independent of Nod2.
Shanahan MT; Carroll IM; Grossniklaus E; White A; von Furstenberg RJ; Barner R; Fodor AA; Henning SJ; Sartor RB; Gulati AS
Gut; 2014 Jun; 63(6):903-10. PubMed ID: 23512834
[TBL] [Abstract][Full Text] [Related]
9. Paneth cells and inflammation dance together in Crohn's disease.
Kaser A; Blumberg RS
Cell Res; 2008 Dec; 18(12):1160-2. PubMed ID: 19043437
[No Abstract] [Full Text] [Related]
10. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
Koslowski MJ; Kübler I; Chamaillard M; Schaeffeler E; Reinisch W; Wang G; Beisner J; Teml A; Peyrin-Biroulet L; Winter S; Herrlinger KR; Rutgeerts P; Vermeire S; Cooney R; Fellermann K; Jewell D; Bevins CL; Schwab M; Stange EF; Wehkamp J
PLoS One; 2009; 4(2):e4496. PubMed ID: 19221600
[TBL] [Abstract][Full Text] [Related]
11. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
Wang G; Stange EF; Wehkamp J
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
[TBL] [Abstract][Full Text] [Related]
12. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of human enteric antimicrobial peptides by NOD2 during differentiation of the paneth cell lineage.
Tan G; Li RH; Li C; Wu F; Zhao XM; Ma JY; Lei S; Zhang WD; Zhi FC
Sci Rep; 2015 Feb; 5():8383. PubMed ID: 25670499
[TBL] [Abstract][Full Text] [Related]
14. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis.
Ogura Y; Lala S; Xin W; Smith E; Dowds TA; Chen FF; Zimmermann E; Tretiakova M; Cho JH; Hart J; Greenson JK; Keshav S; Nuñez G
Gut; 2003 Nov; 52(11):1591-7. PubMed ID: 14570728
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
16. NOD2 mutations predict the risk for surgery in pediatric-onset Crohn's disease.
Lacher M; Helmbrecht J; Schroepf S; Koletzko S; Ballauff A; Classen M; Uhlig H; Hubertus J; Hartl D; Lohse P; von Schweinitz D; Kappler R
J Pediatr Surg; 2010 Aug; 45(8):1591-7. PubMed ID: 20713205
[TBL] [Abstract][Full Text] [Related]
17. Human defensins in Crohn's disease.
Wehkamp J; Fellermann K; Stange EF
Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
[TBL] [Abstract][Full Text] [Related]
18. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
[TBL] [Abstract][Full Text] [Related]
19. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
20. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
Wehkamp J; Stange EF
Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
